Skip to content

Effect of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery

Efficacy of Different Doses of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery With Desoflurane Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03262090
Enrollment
389
Registered
2017-08-25
Start date
2017-09-18
Completion date
2019-05-21
Last updated
2019-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ambulatory Surgical Procedures

Keywords

Emergence Delirium, desoflurane, general anesthesia

Brief summary

Emergence agitation/delirium (EA/ED) is a common complication in pediatric surgery patients, which increases the risk of developing postoperative airway obstruction and respiratory depression. In infants, there is a high incidence of emergence agitation (EA) after desoflurane anesthesia. The aim of the present preliminary study was to determine the safety and efficacy of of intraoperative infusion of dexmedetomidine (DEX) that would prevent postoperative EA and ED in children undergoing day surgery with desoflurane anesthesia

Detailed description

subjects who underwent day surgery were stratified into two age groups as follows: low to 3 years group, and 3-12 years group. Then they were randomly assigned to receive one of six doses of intravenous dexmedetomidine: 0, 0.2, 0.4, 0.6, 0.8 ,1.0ug/kg before skin incision.

Interventions

DRUG0.2ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.2ug/kg intravenous dexmedetomidine before skin incision

DRUG0.4ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.4ug/kg intravenous dexmedetomidine before skin incision

DRUG0.6ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.6ug/kg intravenous dexmedetomidine before skin incision

DRUG0.8ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.8ug/kg intravenous dexmedetomidine before skin incision

DRUG1.0ug/kg dexmedetomidine

subjects were randomly assigned to receive 1.0ug/kg intravenous dexmedetomidine before skin incision

Sponsors

Guangzhou Women and Children's Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Intervention model description

The aim of the present preliminary study was to determine the safety and efficacy of of intraoperative infusion of dexmedetomidine (DEX) that would prevent postoperative EA and ED in children undergoing day surgery with desoflurane anesthesia. Subjects who underwent day surgery were stratified into two age groups as follows: low to 3 years, and 3-9 years. Then they were randomly assigned to receive one of six doses of intravenous dexmedetomidine: 0,0.2, 0.4, 0.6, 0.8 ,1.0ug/kg before skin incision.

Eligibility

Sex/Gender
ALL
Age
4 Months to 15 Years
Healthy volunteers
No

Inclusion criteria

1. patients who undergo elective unilateral inguinal hernia or hydrocele testis day surgery 2. Patients who are American Society of Anesthesiologists classification I and II 3. Patients who are 4 months through 15 years of age

Exclusion criteria

1\. children with history of respiratory tract infection 1 week preoperatively. 2. patients with preoperative liver and/or kidney dysfunction, or with mental abnormalities. 3\. patients with any congenital malformation or acquired disease that could increase the risks of anesthesia and the dose of anesthetics (such as, but not limited to, congenital heart disease, hydronephrosis, nutrition dysplasia). 4. patients with long-term use of sedative or analgesic drugs.

Design outcomes

Primary

MeasureTime frameDescription
incidence of emergence agitation at different time interval after emergenceat 5min, 10min, 20min, 30min, 40min, 50min, 60min, 2h after emergenceemergence agitation was evaluated by five-point scale

Secondary

MeasureTime frameDescription
incidence of emergence delirium at different time interval after emergenceat 5min, 10min, 20min, 30min, 40min, 50min, 60min, 2h after emergenceemergence delirium was evaluated by five-point scale
sedation scales at different time interval after emergenceat 5min, 10min, 20min, 30min, 40min, 50min, 60min, 2h after emergencesedation was evaluated by MOAA/S scores
pain scale at different time interval after emergenceat 5min, 10min, 20min, 30min, 40min, 50min, 60min, 2h after emergencepain scale was evaluated by FLACC

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026